Human Papilloma Virus Vaccine

Known as: HPV vaccine, Recombinant Human Papilloma Virus Vaccine, Human Papillomavirus Vaccines 
A vaccine used to prevent genital warts, cervical cancer, vulvar cancer, and vaginal cancer caused by certain types of human papillomavirus (HPV). It… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1969-2017
010020019692017

Related topics

Related topics

3 relations
Human Papillomavirusrecombinant viral vaccine

Broader (1)

Papillomavirus Vaccines

Related mentions per year

Related mentions per year

1961-2018
1960198020002020
Human Papilloma Virus Vaccine
Human Papillomavirus
Papillomavirus Vaccines
recombinant viral vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.
OBJECTIVE To measure the effect on genital warts of the national human papillomavirus vaccination programme in Australia, which… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised…
BACKGROUND We evaluated the efficacy of the human papillomavirus HPV-16/18 AS04-adjuvanted vaccine against non-vaccine oncogenic… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries.
OBJECTIVE To assess human papillomavirus (HPV) vaccination coverage after demonstration projects conducted in India, Peru, Uganda… (More)
  • table 1
  • figure 1
  • table 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.
BACKGROUND Quadrivalent human papillomavirus (HPV) vaccine has high efficacy in clinical trials but no reports describe its… (More)
  • table 1
  • figure 2
  • table 2
Is this relevant?
2011
2011
Vaccine counseling: a content analysis of patient-physician discussions regarding human papilloma virus vaccine.
OBJECTIVES (1) Describe content and character of patient-physician human papilloma virus (HPV) vaccine discussions; (2) explore… (More)
Is this relevant?
2011
2011
Human papilloma virus vaccines: Current scenario
Genital human papillomavirus (HPV) infection is the most common sexually transmitted infection with an estimated worldwide… (More)
  • table 1
  • table 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Health and economic implications of HPV vaccination in the United States.
BACKGROUND The cost-effectiveness of prophylactic vaccination against human papillomavirus types 16 (HPV-16) and 18 (HPV-18) is… (More)
  • table 1
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines.
 
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
BACKGROUND Effective vaccination against HPV 16 and HPV 18 to prevent cervical cancer will require a high level of sustained… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
The theoretical population-level impact of a prophylactic human papilloma virus vaccine.
BACKGROUND The ongoing development of a vaccine against human papillomavirus (HPV) raises important questions about the impact of… (More)
  • figure 1
  • table 1
  • figure 3
  • figure 2
  • table 2
Is this relevant?